Wall Street Analysts Believe Precision BioSciences (DTIL) Could Rally 307.93%: Here's is How to Trade

Core Viewpoint - Precision BioSciences (DTIL) shows significant upside potential with a mean price target of $39.61, indicating a 307.9$9.71 [1] Price Targets and Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $19.39, suggesting variability in analyst predictions. The lowest estimate of$19 indicates a 95.7% increase, while the highest target of $60.06 suggests a potential surge of 518.5% [2] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [7] Earnings Estimates - Analysts are optimistic about DTIL's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with near-term stock price movements [9] - Over the past 30 days, one estimate has increased, leading to a Zacks Consensus Estimate rise of 127.4% [10] - DTIL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential upside [11]